127 related articles for article (PubMed ID: 15220176)
1. Principles of pharmacogenetics--implications for the anaesthetist.
Iohom G; Fitzgerald D; Cunningham AJ
Br J Anaesth; 2004 Sep; 93(3):440-50. PubMed ID: 15220176
[No Abstract] [Full Text] [Related]
2. Implications of pharmacogenomics for anesthesia providers.
Ama T; Bounmythavong S; Blaze J; Weismann M; Marienau MS; Nicholson WT
AANA J; 2010 Oct; 78(5):393-9. PubMed ID: 21067087
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics: implications for obstetric anesthesia.
Landau R
Int J Obstet Anesth; 2005 Oct; 14(4):316-23. PubMed ID: 16143506
[No Abstract] [Full Text] [Related]
4. Is genetic testing for cytochrome P450 polymorphisms ready for implementation?
Matchar DB; Thakur M
Am Fam Physician; 2007 Aug; 76(3):348, 351. PubMed ID: 17708133
[No Abstract] [Full Text] [Related]
5. Pharmacogenetics and anesthesiologists.
Galley HF; Mahdy A; Lowes DA
Pharmacogenomics; 2005 Dec; 6(8):849-56. PubMed ID: 16296947
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and obstetric anesthesia.
Landau R
Anesthesiol Clin; 2008 Mar; 26(1):183-95, viii-ix. PubMed ID: 18319188
[TBL] [Abstract][Full Text] [Related]
7. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
Musana AK; Wilke RA
WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
9. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
Sikka R; Magauran B; Ulrich A; Shannon M
Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions.
Wilkinson GR
Clin Pharmacol Ther; 2004 Aug; 76(2):99-103. PubMed ID: 15289786
[No Abstract] [Full Text] [Related]
11. [CYP genotyping in psychopharmacological treatment].
Bramness JG
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):480; author reply 480. PubMed ID: 16477294
[No Abstract] [Full Text] [Related]
12. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
13. [CYP genotyping in psychopharmacological treatment].
Rudberg I; Solberg DK; Refsum H
Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2953-5. PubMed ID: 16276380
[No Abstract] [Full Text] [Related]
14. The potential of genotyping.
de Leon J
Science; 2008 Aug; 321(5890):769. PubMed ID: 18687938
[No Abstract] [Full Text] [Related]
15. [Pharmacogenetics: towards personalized medicine].
Gurwitz D; Rehavi M
Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics and lung transplantation: clinical implications.
Burckart GJ; Hutchinson IV; Zeevi A
Pharmacogenomics J; 2006; 6(5):301-10. PubMed ID: 16520825
[No Abstract] [Full Text] [Related]
17. [Comments to the brochure "Genetic tests and drug monitoring" distributed by the Laboratoriet, Epilepsihospitalet in Dianalund].
Línnet K
Ugeskr Laeger; 2004 Jan; 166(1-2):70-1; author reply 71. PubMed ID: 14752999
[No Abstract] [Full Text] [Related]
18. Introduction.
;
Invest New Drugs; 2005 Dec; 23(6):511. PubMed ID: 16391895
[No Abstract] [Full Text] [Related]
19. Pharmacogenetics and obstetric anesthesia.
Landau R
Int Anesthesiol Clin; 2007; 45(1):1-15. PubMed ID: 17215696
[No Abstract] [Full Text] [Related]
20. [Genetic tests give the finishing touch to individual drug dosage].
Sjöqvist F
Lakartidningen; 2003 Feb; 100(8):592-3. PubMed ID: 12640970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
